Infusion Journal
An official publication of the National Home Infusion Association

Editor-in-Chief
Michelle Simpson, PharmD, BCSCP

Associate Editors
Ryan Garst, PharmD, MBA, BCSCP

Jennifer Charron, RN, MSN, MBA

Statistical and Research Methodology Editor
Danell Haines, PhD
D.J. Haines Research Consulting

Managing Editor
Jeannie Counce

Advertising Director
Ashlan Oberholtzer, MS, RD, LD

Editorial Advisory Board
Chris Maksym, RPh, PharmD
University of Michigan (ret.)

Dave Grady
Big Sky IV Care


David Franklin, MSA
Advanced Care Consulting Services


Janice Wilhelm, RN, MBA
Advanced Home Care


Mitra Z. Gavgani, PharmD
Johns Hopkins Home Care Group


Drew Doyle, RPh
Soleo Health


Laila Alqadri, MD
KabaFusion

About Infusion Journal

Infusion Journal is a peer reviewed, scholarly publication that features independent original research and studies on the effects of infusion therapies related to patient outcomes, medication safety, economic analyses, drug stability studies, case studies, and evaluations of innovative clinical services. 

The National Home Infusion Association (NHIA) will publish 3 issues of Infusion Journal in 2022 as a supplement that mails with INFUSION magazine, the association’s flagship publication. All INFUSION magazine subscribers automatically receive Infusion Journal and journal content will be available to the public online as a digital edition. 

2022 Publication Dates and Deadlines
Issue
Deadline for Manuscripts
March/April
November 1, 2021
July/August
March 1, 2022
November/December
July 1, 2022

Information for Authors

Infusion Journal welcomes submissions from authors on topics relevant to infusion therapy administered in the home, clinic, suite, or other setting. Every author listed on a manuscript must declare any real or perceived conflicts of interest and attest to the originality of their work as well as adherence to all applicable ethical standards. Submissions to Infusion Journal must be unpublished work not under consideration elsewhere. 

Specific author guidelines and an author agreement will be forthcoming soon. Please contact infusionjournal@nhia.org if you are interested or have questions about submissions.

Types of Articles Considered for Inclusion in Infusion Journal
Note: Word counts given below are maximum values and do not include the abstract, references, figure legends, or table captions.

Clinical Research Reports (3,500 words)
Clinical research on the effects of infusion therapies, drug stability studies, and evaluations of innovative clinical services performed by nurses, pharmacists, dietitians, technicians, and other professionals.

Practice Research Reports (3,500 words)
Report of an original investigation performed to gain new knowledge through practice and the outcomes of that practice, where full understanding can only be obtained with direct reference to the outcomes. 

Descriptive reports (3,500 words)
Descriptive reports analyze information collected from past events and relates the results of an organization’s environment to its activities. Data may be collected through survey, questionnaire, live forum, technology or another means.

Clinical Reviews (4,000 words)
Literature reviews that focus primarily on a drug or disease and its treatment, with emphasis on analytic reviews of the clinical use of new drugs. 

Case Studies (3,500 words)
Approaches to managing practice-related problems in infusion. Problem solving, not hypothesis testing, is emphasized.

Case Reports (2,500 words)
Articles that (1) describe unusual drug reactions or pharmacotherapy-related issues or uses, or (2) provide valuable information particularly for teaching purposes. Papers should clearly present the case and include all pertinent and appropriate patient information, establish a causal relationship with an objective measurement, explain the case’s contribution to the literature, and describe how the lessons from the case can be applied.

Health Economic Analyses (3,500 words)
Articles that (1) provide a set of analytical techniques to assist in decision making to promote efficiency and equity, (2) provide a way of thinking about health and health care resource use, (3) introduce a thought process that recognizes scarcity and the need to make choices related to resource utilization. 

Primers (4,000 words)
Intended as introductions to various fields of knowledge that are of interest to infusion clinicians. Can be reviews of basic information in areas related to pharmacy, nursing, nutrition, or those further from the mainstream of pharmacy (e.g., advances in nondrug healthcare technology).

Medication-Use Technology (3,500 words)
Describes experiences with and implications of new technologies applied in the medication-use process, including but not limited to computerized prescriber order entry, robotics, automated compounding, bar coding, electronic medical records, and other automation. 

Therapy Updates (4,000 words)
Concise analytic reviews of narrowly defined, important topics in infusion therapy; not intended to be comprehensive reviews of drugs or of diseases and their treatment. Articles that focus on new or emerging standards in drug therapy receive priority.

Clinical Consultations (4,000 words)
Brief advice on how to handle specific drug therapy problems. The answers are based on systematic review of the literature that focuses on the specific question.

Commentaries (2,000 words)
Well-reasoned expressions of opinion on issues related to drug therapy, clinical research, the role of pharmacist, nurses, and dietitians in society, or healthcare.

Peer Review
Submissions undergo a double-blinded peer review process. At least 3 infusion professionals with expertise in the subject area review submitted manuscripts for possible flaws in research design or analysis, conflict of interest, accuracy, and failure to meet clinical best practice.  Reviewers make recommendations to the editorial team regarding the disposition of the manuscript (accept, accept with revisions, or reject). Final decisions regarding publication rest with the Editor-in-Chief.

Following peer review, authors may be asked to revise their submissions. All material is subject to edits for adherence to grammar, and style.  Specific peer review guidelines will be forthcoming soon. Please contact infusionjournal@nhia.org if you are interested in serving as a reviewer. 

Advertising
Infusion Journal will accept a limited number of advertisements. Please contact advertising@NHIA.org for more information.